/
/
/

Epigral Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021
₹705 Cr₹736 Cr₹597 Cr₹587 Cr₹607 Cr₹628 Cr₹645 Cr₹626 Cr₹651 Cr₹525 Cr₹472 Cr₹478 Cr₹455 Cr₹562 Cr₹538 Cr₹556 Cr₹533 Cr₹499 Cr₹422 Cr₹340 Cr₹290 Cr₹259 Cr
₹4 Cr-₹57 L₹6 Cr₹2 Cr₹8 Cr₹3 Cr₹4 Cr₹6 Cr₹2 Cr₹2 Cr₹2 Cr₹1 Cr₹2 Cr₹5 Cr-₹26 L₹2 Cr₹2 Cr₹2 Cr-₹30 L₹2 Cr₹17 L-₹3 L
₹709 Cr₹736 Cr₹603 Cr₹589 Cr₹615 Cr₹631 Cr₹649 Cr₹632 Cr₹654 Cr₹526 Cr₹474 Cr₹479 Cr₹456 Cr₹567 Cr₹538 Cr₹557 Cr₹535 Cr₹501 Cr₹422 Cr₹342 Cr₹291 Cr₹259 Cr
₹569 Cr₹609 Cr₹537 Cr₹497 Cr₹485 Cr₹488 Cr₹496 Cr₹480 Cr₹508 Cr₹400 Cr₹380 Cr₹402 Cr₹391 Cr₹438 Cr₹402 Cr₹401 Cr₹367 Cr₹345 Cr₹303 Cr₹261 Cr₹219 Cr₹199 Cr
₹183 Cr₹168 Cr₹108 Cr₹134 Cr₹172 Cr₹177 Cr₹186 Cr₹184 Cr₹179 Cr₹157 Cr₹125 Cr₹109 Cr₹97 Cr₹159 Cr₹166 Cr₹182 Cr₹189 Cr₹177 Cr₹141 Cr₹103 Cr₹93 Cr₹80 Cr
₹7 Cr₹16 Cr₹11 Cr₹22 Cr₹23 Cr₹12 Cr-₹7 L₹27 Cr₹14 Cr₹14 Cr₹20 Cr₹21 Cr₹18 Cr₹19 Cr₹21 Cr₹14 Cr₹11 Cr₹12 Cr₹10 Cr₹10 Cr₹12 Cr₹4 Cr
₹133 Cr₹111 Cr₹55 Cr₹70 Cr₹107 Cr₹131 Cr₹154 Cr₹124 Cr₹131 Cr₹113 Cr₹74 Cr₹56 Cr₹48 Cr₹110 Cr₹114 Cr₹142 Cr₹156 Cr₹144 Cr₹109 Cr₹71 Cr₹59 Cr₹55 Cr
₹99 Cr₹82 Cr₹39 Cr₹52 Cr₹160 Cr₹87 Cr₹104 Cr₹81 Cr₹86 Cr₹77 Cr₹49 Cr₹38 Cr₹32 Cr₹77 Cr₹77 Cr₹92 Cr₹108 Cr₹99 Cr₹70 Cr₹47 Cr₹37 Cr₹33 Cr

Share Price Live Stats

Open (₹)1,230.00
Volume (₹)22,789.00
High (₹)1,254.80
Upper Circuit1,484.00
Low (₹)1,225.00
Lower Circuit989.40
Prev Close1,236.70
52W High (₹)1,814.70
Price1,242.00
52W Low (₹)807.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)5349.74 Cr
Div. Yield (%)0.40
PE Ratio19.74
Debt to Equity0.25
Price to Book1.57
Book Value514.94
EPS (TTM)62.82
Face Value10.00
ROE (%)16.09

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SOLARINDSNSE
PIDILITINDNSE
SRFNSE
FLUOROCHEMNSE
NAVINFLUORNSE
GODREJINDNSE
DEEPAKNTRNSE
AETHERNSE
ATULNSE
AARTIINDNSE
EPIGRALNSE
LTP
1W Low
1W High
Market cap (₹)
21520+1120 (5.49%)
19810
21695
1,93,746Cr
1628.2-1.3 (-0.08%)
1612.40
1687.70
1,66,118Cr
2559.1-30.8 (-1.19%)
2532.20
2648
77,219Cr
4617.6-153.6 (-3.22%)
4550
4850
51,537Cr
8644+126.5 (1.49%)
8275.50
8740
44,624Cr
1167.7+0.2 (0.02%)
1128.50
1215.90
38,937Cr
1722.5-40.4 (-2.29%)
1705.70
1820
23,559Cr
1641.4-55.4 (-3.26%)
1626.60
1707.80
21,984Cr
6416-43.5 (-0.67%)
6358
6642.50
19,036Cr
502.85-37.5 (-6.94%)
496.10
540.60
18,200Cr
1242+9.2 (0.75%)
1196.60
1254.80
5,350Cr

Key Highlights of Epigral Ltd’s P&L

In 2026-03-31, Epigral Ltd reported total revenue of ₹2542.16Cr, compared with ₹2565.34Cr in 2025-03-31, reflecting Epigral Ltd turnover.

Depreciation was ₹168.29Cr and finance costs were ₹71.96Cr in 2026-03-31

Profit Before Tax (PBT) has been ₹340.76Cr in 2026-03-31 as compared to ₹541.09Cr in 2025-03-31.

Net Profit (PAT) was ₹331.97Cr in 2026-03-31 compared with ₹357.69Cr in 2025-03-31.

Earnings per share (EPS) were ₹76.95 in 2026-03-31, compared with ₹82.91 in 2025-03-31.